Lobular MBC is different from ductal MBC. Lobular MBC is harder to detect, often detected at a later stage, and spreads to different places in the body. Most lobular breast cancers are hormone receptor-positive (ER+ and/or PR+) and HER2-negative.
Visit the links below to learn more about lobular MBC and the latest research on this type of MBC.
Introduction to Lobular MBC
- Lobular Breast Cancer Alliance: What is Metastatic Lobular Breast Cancer?
- MD Anderson Cancer Center: What is Lobular Breast Cancer?
- Breast Cancer Research Foundation: Invasive Lobular Carcinoma: Symptoms, Treatment, and Research
Recent Lobular MBC Research
- Lobular Breast Cancer Alliance (Video): Lobular Breast Cancer Research Presented at SABCS in 2022
- Ohio State University: Multi-Center Study Sheds Light on Lobular MBC
- Practice Update: Immunotherapy for Lobular MBC
- Practice Update: Comparison of Lobular and Ductal MBC
Clinical Trials for Metastatic Lobular Breast Cancer
- Metastatic Trial Search: Trials open to people with metastatic lobular breast cancer
- Metastatic Trial Search: Trials specific for metastatic lobular breast cancer
Last Modified on June 1, 2023